Company / R&D per Share
IRADIMED CORP R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.23
FY2025
5-year range
$0.12 / $0.23
FY2021-FY2025
Trend
+4.6%
vs FY2024
Sector context
#100 of 108
Health Care
What the data says
Among 108 Health Care companies, IRADIMED CORP is in the bottom 7% for r&d per share. R&D per Share has fluctuated over the past 10 years, ranging from $0.10 in FY2016 to $0.23 in FY2025.
Based on SEC 10-K filings.
0.23 in FY2025 with a 5-year CAGR of +7.7%.
Improved from $0.23 to $0.23 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +15.7%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 108This company $0.23 Sector average $2.07
▼
-88.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 4.6% year-over-year.
- Ranks #100 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.23 | +4.6% |
| FY2024 | $0.22 | -1.5% |
| FY2023 | $0.23 | +50.1% |
| FY2022 | $0.15 | +30.0% |
| FY2021 | $0.12 | -28.0% |
| FY2020 | $0.16 | +24.0% |
| FY2019 | $0.13 | +2.5% |
| FY2018 | $0.13 | -22.7% |
| FY2017 | $0.16 | +72.1% |
| FY2016 | $0.10 | -3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026